-
March 5, 2024
Congressmen Bishop and Fitzpatrick Introduce Bipartisan Bill to Support FDA-Cleared Research into Treatments and Cures for Disease
-
July 29, 2022
Biomedical financing must not be a casualty of the current downturn
-
March 23, 2022
Few & Far Between: Conversations About Rare Disease Research featuring Karen Petrou and David Brint – BioBonds
-
December 23, 2021
What We’re Looking Forward To in 2022
-
November 18, 2021
A financial innovation that could cure diseases
-
October 6, 2021
COVID Revealed What Science Can Do When Funding is Found
-
July 12, 2021
BioBonds Use Wall Street Tools to Fund Medical Research
-
May 28, 2021
Jump Start Stalled Medical Research, U.S. Rep. Rush Says
-
May 24, 2021
U.S. Bond Program Proposed to Spur R&D for Unmet Medical Needs
-
May 24, 2021
JPMorgan Tries Again on Healthcare After Haven Implodes
-
May 24, 2021
Bipartisan House Bill Seeks New $30B ‘BioBonds’ Loan Program to Reinvigorate Clinical Trials
-
May 24, 2021
Lawmakers Pitch a Bill to Create $30 Billion in ‘BioBonds’ to Jumpstart Drug Development
-
May 21, 2021
House ‘BioBonds’ Bill Aims to Get Medical Research Back on Track
-
May 21, 2021
Foundation Fighting Blindness Applauds Introduction of LOANS for Biomedical Research Act
-
May 9, 2021
Foundation Fighting Blindness Endorses ‘Eye Bonds’ Legislation
-
April 23, 2019
Bio Bonds: Unlocking Billions for Biomedical Treatment and Cure
-
August 22, 2018
Overview: Translational Biomedical Research Funding in Advanced, Market-Based Economies